ZURICH (Reuters) - Drugmaker Polyphor is hiring new managers and shifting focus after a trial of its top antibiotic hopeful proved too dangerous to continue, the Swiss company said on Wednesday. Chief ...
Polyphor AG (VTX:POLN) shareholders will doubtless be very grateful to see the share price up 53% in the last month. But that isn't much consolation to those who have suffered through the declines of ...
Polyphor (SIX: POLN) and EnBiotix Inc., a privately held late clinical-stage rare disease company currently focused on products for rare, chronic respiratory diseases, today announced closing of the ...
ZURICH (Reuters) - Books for Swiss drugmaker Polyphor's (POLN.S) initial public offering are already covered less than half way through the subscription period, two people familiar with the ...
Allschwil, Switzerland, July 31, 2013 - Polyphor, a research-driven pharmaceutical company and leader in the discovery and development of macrocyclic drugs, today announced that Boehringer Ingelheim ...
EQS Group-Ad-hoc: Polyphor AG / Key word(s): Personnel Polyphor appoints Frank Weber as new Chief Medical and Development Officer 27-Jun-2019 / 07:00 CET/CEST Release of an ad hoc announcement ...
Co-primary endpoint of the study objective response rate (ORR) was not met The board of directors is undergoing a strategic assessment regarding the future of the company ALLSCHWIL, Switzerland, June ...
Polyphor is closing its failed phase 3 breast cancer clinical trial and planning to lay off staff to lower its costs. The Swiss biotech said its “initial” restructuring will affect 29 positions and it ...
ALLSCHWIL, SWITZERLAND / ACCESSWIRE / December 30, 2021 / Polyphor AG (SIX:POLN) and EnBiotix Inc. today announced the closing of the merger of the two companies and the change of name of the combined ...
Polyphor AG (SIX: POLN) today provided an update regarding the recently announced evaluation of strategic options. This review has become necessary following the negative results of the FORTRESS study ...
Release of an ad hoc announcement pursuant to Art. 53 KR The issuer is solely responsible for the content of this announcement. Allschwil, Switzerland, December 22, 2020 Polyphor receives approval to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback